Gregory Schwartz

23PUBLICATIONS
62CO-AUTHORS
Injury preventionEvolutionary computationCardiology (incl. cardiovascular diseases)Medical biochemistry - lipidsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 05, 2026
The safety of low lipoprotein(a): a story not yet fully told.

|Mar 30, 2026
Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials.

Sreekanth Vemulapalli, Karla Pena Guerra, Daniel Wojdyla

|Jan 28, 2026
Inclisiran in Patients with CKD: Post Hoc Pooled Analysis of Three Phase 3 Trials.

Ulf Landmesser, Kausik K Ray, Frederick J Raal

|Dec 01, 2025
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome.

Sotirios Tsimikas, Michael Szarek, Christa M Cobbaert

|Sep 25, 2025
Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy.

Esther Reijnders, Patrick M Bossuyt, J Wouter Jukema

|Aug 23, 2025
Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial.

Gregory P Geba, Kusha A Mohammadi, Amy Damask

Pageof 4

Frequent Collaborators

10 joint publications

Philippe Gabriel Steg

10 joint publications

Michael Szarek

8 joint publications

Deepak L Bhatt

8 joint publications

J Wouter Jukema